MAPT and Cognitive impairment: In conclusion, these findings provide strong evidence that a number of NSAIDs could be useful by blocking GSK3 enzyme leading to an attenuation in the levels of phosphorylated tau protein, resulting in a reduced risk of developing cognitive impairment (Bradbury, 2004).